1. The Need for Pharmacoeconomic Evaluations in the NHS

   • John P. Griffin

   Current Opinion 28 November 2012 Pages: 241 - 250

2. Methodological Quality of Economic Modelling Studies

   • Tom Jefferson
   • Vittorio Demicheli

   Current Opinion 28 November 2012 Pages: 251 - 257

3. Reporting Format for Economic Evaluation

   • Mark J. C. Nuijten
   • Marja H. Pronk
   • Ary van der Kuy

   Leading Article 28 November 2012 Pages: 259 - 268

4. Outcomes of Pharmacological and Surgical Treatment for Obesity

   • Jennifer Cerulli
   • Margaret Malone

   Review Article 28 November 2012 Pages: 269 - 283

5. Cost Analysis of Palliative Care for Terminally Ill Cancer Patients in the UK After Switching from Weak to Strong Opioids

   • Julian F. Guest
   • Warren M. Hart
   • Ronald F. Cookson

   Original Research Article 28 November 2012 Pages: 285 - 297

6. The Economic Impact of Parkinson’s Disease

   • Richard C. Dodel
   • Marikka Singer
   • Wolfgang H. Oertel

   Original Research Article 28 November 2012 Pages: 299 - 312

7. Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults

   • Gilles Berdeaux
   • Antoine Lafuma
   • Francis Fagnani

   Original Research Article 28 November 2012 Pages: 313 - 322

8. Costs and Effects Associated with a Community Pharmacy-Based Smoking-Cessation Programme

   • Grainne E. Crealey
   • James C. McElnay
   • Ciaran O’Neill

   Original Research Article 28 November 2012 Pages: 323 - 333

9. Methodological Quality of Economic Modelling Studies

   • Michelle Wilde

   Correspondence 28 November 2012 Pages: 335 - 335